Join the Linzess group to help and get support from people like you.
Linzess News
FDA Approves Linzess to Treat Constipation in Children, Teens
WEDNESDAY, June 14, 2023 – The U.S. Food and Drug Administration approved Linzess (linaclotide) as a once-daily treatment for pediatric patients ages 6 to 17 years with functional constipation. The...
Ironwood Pharmaceuticals Announces FDA Approval of New Indication for Linzess (linaclotide) for the Treatment of Functional Constipation in Pediatric Patients Ages 6-17 Years-Old
BOSTON--(BUSINESS WIRE) June 12, 2023 – Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has approved...
U.S. FDA Approves 72 mcg Dose of Linzess (linaclotide) for Adults with Chronic Idiopathic Constipation
CAMBRIDGE, Mass. and DUBLIN, Jan. 26, 2017 /PRNewswire/ – Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and Allergan plc (NYSE: AGN) announced today that the U.S. Food and Drug Administration (FDA)...
Ask a question
To post your own question to this support group, sign in or create an account.